© Jabil Circuit Inc Electronics Production | July 06, 2018
The Healthcare supply chain needs a technology revolution
Think about the number of items you use in your daily life that are more than 20 years old. Most likely, your car, mobile devices and home appliances are all less than 20 years old.
In sharp contrast, many devices used in the medical industry, items that are meant to ensure people’s health and save lives, utilize 20-year-old technology. It’s time to transform the healthcare supply chain. Compared with other markets, like the high-tech industry, change has been gradual in the medical device field. Technology does not drive the medical device industry, proven therapy does. Therapy, paired with the requirements of a regulated industry create a pace of change that is inconsistent with the technology that exists in their products. The conservative approach to product development and launch constructed by regulating bodies like the U.S. Food and Drug Administration influence the pace of change and new releases to the market. This rigorous approval process is something we all can be thankful for. Significant cost for recertification and the sheer complexity of both the products and the process has discouraged manufacturers from reevaluating the healthcare supply chain. The Medical Device Industry and the Life Science Diagnostic Industry are like razor and razorblade industries. While you may continue to enhance the razor blades, this does not mean that you need to redesign the razor itself. The same thinking applies to healthcare. Redesigning existing products or launching new ones are not priorities if they are not needed in the market. Recertification risk, return on new product design investment and patient safety drive the extended product lifecycles to be at 10-15 years as commonplace. Unfortunately, that is no longer a luxury that can be afforded by the healthcare supply chain. Electronic component market conditions and corresponding shortages are affecting all types of industries — from mobile technology to aerospace and defense — and are starting to take a toll on the healthcare industry. Although these component families are commonly associated with the tech industry, they have played a prominent role in the medical market over the past decade. Ten years ago, Livemint predicted that medical devices would be the next big market for semiconductors, and other component devices, forecasting 12 percent annual growth. Two years later, ECN touted that semiconductor demands by the healthcare industry for diagnostic and monitoring devices were influencing semiconductor research. Now, everything from pacemakers to blood pressure monitors and other critical products rely on semiconductors along with other electronic components. This requirement will only grow with the focus on personalized medicine, the change in the point of care and connected health. Some of these components, which may cost as little as a few pennies a piece and rarely seemed worth a product redesign to future-proof them are now slowing and even shutting down production lines across industries due to low supply. As component supplier's prices were driven down following the last recession, many suppliers focused their investment and growth plans on newer, high-growth and high-margin components. Due to this transition and a few other factors, the supply of older generation products is not keeping up with demand, resulting in a supply shortage. Lead times for some of these products can stretch as long as a year, and in some cases, healthcare manufacturers cannot acquire the parts necessary to support production requirements. A New Healthcare Supply Chain Reality: The Past Can’t Dictate the Future Component shortages are not a new challenge for the healthcare industry. In the past, healthcare manufacturers have opted to simply pay higher premiums for parts or buy them in bulk and hold them on their balance sheets. However, the problem with this severe and unprecedented shortage is that there are fewer parts left to buy and hold in inventory and suppliers are driving old technology packages into end-of-life. This point tends to perplex some of our healthcare customers. They'll quickly point out that they clearly communicate their product needs in advance, so it is frustrating that component suppliers cannot deliver on some of these older generation product families. That may well be true, but the problem is that healthcare manufacturers are used to working with legacy parts, however, in the current environment some of these components will be harder and harder to procure. In large part it is basic economics. Industries such as automotive, mobility and network infrastructure drive a very large percentage of the overall electronics pie. In fact, a large percentage of the product’s cost of goods in automotive is electronics. Healthcare and diagnostic products are generally much lower volume in comparison and electronics are a much smaller percentage of the overall product’s cost of goods. Connected Health is Transforming the Healthcare Supply Chain There hasn’t been excessive need for products to be redesigned at a pace consistent with technology in the past, but connected health is changing the healthcare supply chain. This point is even more salient when you consider how fast products move in an Internet of Things (IoT) world. Big data and other emerging technologies are changing how patients are seen, where they experience care, how their information is managed, all while shortening the development and approval of new healthcare products. A few years ago, there were only a few connected health devices on the market. Today, there are hundreds. Healthcare is going through a transformation, which are lowering healthcare costs. The collision of proven therapies with the industry-driven need for new technology is driving healthcare manufacturers to reinvent how they defend current markets, capture new emerging markets and secure their commitments to shareholders. Healthcare manufacturers must drive a cultural change to include speed and technology as major drivers to their product strategies. This process becomes more complex when brands are incredibly committed and connected to patient safety. It creates an opportunity to innovate not only in therapy and devices but in the innovation process. New products must include plans for securing the healthcare supply chain. It’s time for the healthcare supply chain to move from being a technology laggard to a technology leader – or at least be somewhere in the middle. The Opportunity Cost of Delaying the Healthcare Supply Chain Given the nature of the industry up until now, today's turbulent environment is foreign to healthcare manufacturers. Times aren't changing, they have changed. Their strategies must not only include safe therapy and product development but must include how to manage the misalignment in product and technology lifecycles. In combination with the continued pressure on cost and the global growth in the need for affordable healthcare, there must be a plan for global manufacturing and supply chain. Healthcare manufacturers have lamented how expensive a redesign is, especially considering that it typically takes 18 months on average to bring a product to market. Unfortunately, this is the cost of doing business today. Every day we review the revenue impact to our customers, based on the impact of legacy technology shortages. In these conversations, focusing on the cost and risk of revenue and profit streams generally lead to a very simple answer. When coaching healthcare customers through this process, we try to help them quantify the value of a redesign or the opportunity cost of not doing a redesign. We discuss factors such as:
Author: Joe McBeth, Vice President, Global Supply Chain, Nypro Healthcare. This article was originally published on the Jabil Blog.
- the component lifecycle analysis and exposure
- impact from a perspective of immediacy and revenue loss
- how long they can manufacture with available components
- how much revenue they will miss based on the probable failures in the product’s supply pipelines
- the cost and time to redesign a product and secure the proper regulatory approvals before production can begin again
- the capabilities available or required for success
- Act today. Immediately perform a lifecycle analysis of your products and begin the design process to secure your revenue pipeline. In our healthcare portfolio, there is not one customer unaffected by the current market conditions.
- Do not choose a new component or set a project timeline without listening to your supply base. The electronics market moves faster and is more dynamic than most others. To ensure success, link your product development teams with supply chain teams. Make market conditions, supplier performance and preference as well as the technology roadmap a regular part of the discussion. Map your technology roadmaps against product lifecycles. These are foundational for success.
- Stay ahead of the technology curve. Don't be tempted and opt for slightly older, lower cost parts. If, for example, you choose a Wi-Fi component that is five or seven years into its lifecycle, that component will be seven or nine years old by the time your product goes to market. In addition to offering outdated technology in your product, you’ll likely be putting your product at risk since that part may soon become obsolete.
- Consider modular design. The FDA approval process certainly lengthens the redesign project timeline. To shorten this, opt for a modular design where possible. This may allow you to keep up with technology and only need to change the affected module. It won’t change the form fit or function of the product and will reduce or eliminate the regulatory requirement.
- Secure your future relevancy within the supply chain. It is no longer enough to have a working product, you must also have an effective and efficient healthcare supply chain. To remain relevant in the future you must continue to make investments that create speed and efficiency for both your customers and your suppliers. This requires continued development of a strong digital backbone. Relevancy is not simply tied to technology or digital infrastructure, it is also strongly tied to managing geographic cost and complexity. The world is a much smaller and more technologically capable place compared to 20 years ago. If you are buying raw printed circuit boards, capacitors or even metal machining that are manufactured in the United States, you are likely utilizing a more expensive opportunity from a supply chain that likely has not kept pace with some of the leading geographies.
- Follow the simple economic theory of "opportunity cost". Is it more valuable for you to continue to invest in the development of new manufacturing and supply chain solutions to remain relevant and efficient, or is it better for you to invest in developing and expanding your brand?
Author: Joe McBeth, Vice President, Global Supply Chain, Nypro Healthcare. This article was originally published on the Jabil Blog.
U.S. polysilicon makers laud Phase 1 of China deal The United States’ three remaining manufacturers of polysilicon expressed appreciation to President Trump and praised U.S. negotiators for securing the Chinese commitment to purchase U.S. polysilicon in the first phase of the U.S.-China trade deal.
Dupont explores divestiture of electronics unit Following its recent USD 26.2 billion deal to sell off its nutrition business, DuPont de Nemours Inc. is weighing a divestiture of its electronics unit, according to people familiar with the matter.
AMD bolsters exec leadership team AMD has announced several promotions and one new hire to its senior leadership team, in an effort to enable the company’s continued growth in the high-performance computing, graphics and visualization technologies market.
Webasto opens new battery centre in Jiaxing Webasto has inaugurated its new roof plant and battery center in Jiaxing (Zhejiang Province) close to Shanghai.
Sponsored content by CMLCML manufactures Insulated Metal Substrate (IMS) solutions Printed circuit boards (PCBs) plays an important role in our day to day life. Whether it’s the car you’re driving, the phone that you’re scrolling through or computers that you’re sending emails from. What happens when you use heat generating components on a PCB? That’s right, cooling is needed!
Panasonic to expand its manufacturing footprint in India Panasonic is looking to build a new wiring device factory in southern India. The new factory is scheduled to start production in autumn 2021, responding to the increased demand in the country.
Season Group strengthens wireless R&D & manufacturing capability Season Group has invested in, and installed, two high-speed and high-precision wireless communication testers - Rohde & Schwarz’s R&S CMW500 Wideband Radio Communication Tester and R&S CMW100 Communications Manufacturing Test Set.
Rocket Lab expands capabilities in So Cal Rocket Lab announced this week it will open a new facility to serve as its corporate headquarters and provide increased production capacity.
PCB Piezotronics unveils new clean rooms PCB Piezotronics Inc., a wholly owned subsidiary of MTS Systems Corporation, has announced the completion of environmentally controlled clean rooms at their DePew, New York facility.
European loudspeaker company brings production back home Difficulties manufacturing smaller design series among reasons for the decision to return back to base.
China only region to register pure-play foundry market growth Rise of China-based fabless IC suppliers offers increased opportunities for foundries, IC Insights states in a recent report.
Mycronic receives first SLX order Swedish production equipment specialist, Mycronic, has recieved their very first order of its mask writer SLX.
600 new German jobs as VARTA expands production again The lithium-ion battery market continues to experiencing growth, currently the market is poised to continue to move forward with an annual growth of about 30% – and VARTA wants a big piece of the pie.
FTG achieves S9100D certification at acquired PCB fab Firan Technology Group Corporation has completed and received AS9100D Certification from SAI Global Ltd. for its recently acquired PCB manufacturing facility located in Fredericksburg, Virginia USA (formerly Colonial Circuits Inc.).
Dutch block sale of technology, China miffed Following ASML’s denial of an export license by the Dutch government to sell a piece of critical chip-making technology to the Chinese, China’s ambassador to the Netherlands has issued a statement expressing his country’s displeasure.
DuPont aids S. Korea in photoresist shortage The office of Korea’s Ministry of Trade, Industry, Sung Yun-mo, met with DuPont President Jon Kemp last week to confirm DuPont’s investment in the country’s need for diversification of its EUV photoresist supply.
Volvo building U.S. battery assembly plant In preparation for bringing a new line of electric vehicles to the U.S. market, Volvo announced it will build a battery assembly plant at its existing facility in Ridgeville, South Carolina.
New game consoles expected to trigger demand surge for graphics DRAM and SSD's TrendForce expects the year-end release of new generation game consoles to trigger a demand surge of graphics DRAM and SSD's during the second half of 2020.
A new year begins with new machinery at Swedish Microwave In Motala, Sweden sits Europe’s oldest manufacturer of Low Noise Block down-converters (LNB) for the global satellite market, namely Swedish Microwave (SMW). The company is now kicking off 2020 with an investment in production.
Lucid eyeing April reveal of pre-production sedan Luxury EV manufacturer Lucid has announced that production is underway in Silicon Valley of 80 beta prototypes of its luxury sedan, Lucid Air, to be unveiled in April in New York City.
Ideal Industries moving the ball forward at Cree Following its March announcement that Cree had sold off the entirety of its lighting business to Ideal Industries in a USD 310 million deal, Ideal said it would remain dedicated to pumping investment dollars into the now privately-held Cree Lighting.
Former pSemi exec and CEO Jim Cable retires pSemi Corporation has announced the retirement of former CEO and long-term executive Jim Cable.
Rohde & Schwarz inks agreement to use Benchmark's muscles The German electronics group has signed a strategic agreement with US EMS provider, Benchmark Electronics, to enhance its manufacturing capacities.
Stoneridge appoints new VP of operations Stoneridge Inc. has announced Kevin Heigel as its new vice president of operations.
Gartner: Worldwide semiconductor revenue declined 11.9% in 2019 Intel reclaimed top spot in global semiconductor market; Samsung moved to no. 2.Load more news